Breaking News, Collaborations & Alliances

Quintiles, Dako Form Drug-Diagnostic Alliance

Quintiles and Dako, a provider of tissue-based cancer diagnostics, have entered a strategic alliance to advance personalized medicine through the development of targeted therapies and companion diagnostics.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Quintiles and Dako, a provider of tissue-based cancer diagnostics, have entered a strategic alliance to advance personalized medicine through the development of targeted therapies and companion diagnostics. The two companies will offer integrated drug-diagnostic development services and companion diagnostic products. Dako will develop cancer diagnostic tests, and Quintiles will conduct the tests as part of the clinical validation. Their first collaboration will support AstraZeneca’s development ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters